Association of demographics, HCV co‐infection, HIV‐1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV‐1 Surveillance Network

Abstract Introduction Late diagnosis of the human immunodeficiency virus (HIV) is a major concern epidemiologically, socially and for national healthcare systems. Although the association of certain demographics with late HIV diagnosis has been reported in several studies, the association of other factors, including clinical and phylogenetic factors, remains unclear. In the present study, we conducted a nationwide analysis to explore the association of demographics, clinical factors, HIV‐1 subtypes/circulating recombinant form (CRFs) and genetic clustering with late HIV diagnosis in Japan, where new infections mainly occur among young men who have sex with men (MSM) in urban areas. Methods Anonymized data on demographics, clinical factors and HIV genetic sequences from 39.8% of people newly diagnosed with HIV in Japan were collected by the Japanese Drug Resistance HIV‐1 Surveillance Network from 2003 to 2019. Factors associated with late HIV diagnosis (defined as HIV diagnosis with a CD4 count <350 cells/μl) were identified using logistic regression. Clusters were identified by HIV‐TRACE with a genetic distance threshold of 1.5%. Results Of the 9422 people newly diagnosed with HIV enrolled in the surveillance network between 2003 and 2019, 7752 individuals with available CD4 count at diagnosis were included. Late HIV diagnosis was observed in 5522 (71.2%) participants. The overall median CD4 count at diagnosis was 221 (IQR: 62–373) cells/μl. Variables independently associated with late HIV diagnosis included age (adjusted odds ratio [aOR] 2.21, 95% CI 1.88–2.59, ≥45 vs. ≤29 years), heterosexual transmission (aOR 1.34, 95% CI 1.11–1.62, vs. MSM), living outside of Tokyo (aOR 1.18, 95% CI 1.05–1.32), hepatitis C virus (HCV) co‐infection (aOR 1.42, 95% CI 1.01–1.98) and not belonging to a cluster (aOR 1.30, 95% CI 1.12–1.51). CRF07_BC (aOR 0.34, 95% CI 0.18–0.65, vs. subtype B) was negatively associated with late HIV diagnosis. Conclusions In addition to demographic factors, HCV co‐infection, HIV‐1 subtypes/CRFs and not belonging to a cluster were independently associated with late HIV diagnosis in Japan. These results imply the need for public health programmes aimed at the general population, including but not limited to key populations, to encourage HIV testing.

[1]  S. Oka HIV testing in COVID-19 pandemic and beyond in Japan. , 2021, Global health & medicine.

[2]  M. Fararouei,et al.  Late diagnosis of HIV infection and its associated factors in Shiraz, Southern Iran: a retrospective study , 2021, AIDS care.

[3]  R. Paredes,et al.  Determinants of HIV-1 Late Presentation in Patients Followed in Europe , 2021, Pathogens.

[4]  A. Kelleher,et al.  Subtype‐specific differences in transmission cluster dynamics of HIV‐1 B and CRF01_AE in New South Wales, Australia , 2021, Journal of the International AIDS Society.

[5]  Wei He,et al.  Dynamics of HIV-1 Molecular Networks Reveal Effective Control of Large Transmission Clusters in an Area Affected by an Epidemic of Multiple HIV Subtypes , 2020, Frontiers in Microbiology.

[6]  M. Horberg,et al.  Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016 , 2020, JAMA network open.

[7]  R. Guy,et al.  Trends in late and advanced HIV diagnoses among migrants in Australia; implications for progress on Fast-Track targets , 2020, Medicine.

[8]  Y. Liang,et al.  HIV‐1 genotype is independently associated with immunodeficiency progression among Chinese men who have sex with men: an observational cohort study , 2019, HIV medicine.

[9]  T. Kawahata,et al.  Estimating HIV-1 incidence in Japan from the proportion of recent infections , 2019, Preventive medicine reports.

[10]  T. Geijtenbeek,et al.  Sexually transmitted hepatitis C virus infections: current trends, and recent advances in understanding the spread in men who have sex with men , 2019, Journal of the International AIDS Society.

[11]  R. Hayes,et al.  Impact of a universal testing and treatment intervention on HIV incidence in Zambia and South Africa: results of the HPTN 071 (PopART) community-randomized trial , 2019, The New England Journal of Medicine.

[12]  N. Pantazis,et al.  Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort , 2019, AIDS.

[13]  Hiroshi Nishiura,et al.  Estimating the incidence and diagnosed proportion of HIV infections in Japan: a statistical modeling study , 2019, PeerJ.

[14]  V. Cooper,et al.  Factors associated with testing for HIV in people aged ≥50 years: a qualitative study , 2018, BMC Public Health.

[15]  H. Luma,et al.  Late presentation to HIV/AIDS care at the Douala general hospital, Cameroon: its associated factors, and consequences , 2018, BMC Infectious Diseases.

[16]  Steven Weaver,et al.  HIV-TRACE (TRAnsmission Cluster Engine): a Tool for Large Scale Molecular Epidemiology of HIV-1 and Other Rapidly Evolving Pathogens. , 2018, Molecular biology and evolution.

[17]  R. Hogg,et al.  The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions , 2017, Journal of acquired immune deficiency syndromes.

[18]  Mahbubur Rahman,et al.  The HIV care cascade: Japanese perspectives , 2017, PloS one.

[19]  D. Fierer,et al.  Shedding of Hepatitis C Virus Into the Rectum of HIV-infected Men Who Have Sex With Men , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Ben Murrell,et al.  Social and Genetic Networks of HIV-1 Transmission in New York City , 2017, PLoS pathogens.

[21]  Art F. Y. Poon,et al.  Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study , 2016, The lancet. HIV.

[22]  J. Sterne,et al.  Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  P. Phanuphak,et al.  Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD. , 2016, AIDS research and human retroviruses.

[24]  P. Reiss,et al.  Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996–2014: results from a national observational cohort , 2016, BMJ Open.

[25]  Derek R. Smith,et al.  HIV testing and attitudes among the working-age population of Japan: annual health checkups may offer an effective way forwards , 2015, Industrial health.

[26]  S. Oka,et al.  What Triggers a Diagnosis of HIV Infection in the Tokyo Metropolitan Area? Implications for Preventing the Spread of HIV Infection in Japan , 2015, PloS one.

[27]  D. Fierer,et al.  Acute HCV in HIV-Infected MSM: Modes of Acquisition, Liver Fibrosis, and Treatment , 2015, Current HIV/AIDS Reports.

[28]  J. del Romero,et al.  Effects of region of birth, educational level and age on late presentation among men who have sex with men newly diagnosed with HIV in a network of STI/HIV counselling and testing clinics in Spain. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[29]  P. Harrigan,et al.  The impact of clinical, demographic and risk factors on rates of HIV transmission: a population-based phylogenetic analysis in British Columbia, Canada. , 2015, The Journal of infectious diseases.

[30]  R. Geskus,et al.  Stabilizing Incidence of Hepatitis C Virus Infection Among Men Who Have Sex With Men in Amsterdam , 2014, Journal of acquired immune deficiency syndromes.

[31]  R. Detels,et al.  Baseline CD4 Cell Counts of Newly Diagnosed HIV Cases in China: 2006–2012 , 2014, PloS one.

[32]  Anne M Johnson,et al.  Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE) , 2013, PLoS medicine.

[33]  D. Richman,et al.  HIV-1 Clade B pol Evolution following Primary Infection , 2013, PloS one.

[34]  Ming-Siang Huang,et al.  Slow immunological progression in HIV-1 CRF07_BC-infected injecting drug users , 2013, Emerging Microbes & Infections.

[35]  J. Willig,et al.  Late Diagnosis, Delayed Presentation and Late Presentation in HIV: Proposed Definitions, Methodological Considerations and Health Implications , 2013, Antiviral therapy.

[36]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[37]  H. Stellbrink,et al.  Late presentation for HIV diagnosis and care in Germany , 2012, HIV medicine.

[38]  S. Oka,et al.  Trends in early and late diagnosis of HIV-1 infections in Tokyoites from 2002 to 2010. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[39]  Louisa Degenhardt,et al.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.

[40]  Lei Wang,et al.  Prevention of HIV-1 infection with early antiretroviral therapy. , 2011, The New England journal of medicine.

[41]  H. Krentz,et al.  Despite CD4 cell count rebound the higher initial costs of medical care for HIV-infected patients persist 5 years after presentation with CD4 cell counts less than 350 μl , 2010, AIDS.

[42]  Richard D Moore,et al.  Late presentation for human immunodeficiency virus care in the United States and Canada. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  A. Ogawa,et al.  [The role of oncology nurse in palliative care team--activities of oncology certified nurse specialist in palliative care team at National Hospital Organization Osaka National Hospital]. , 2007, Gan to kagaku ryoho. Cancer & chemotherapy.

[44]  G. Marks,et al.  Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA , 2006, AIDS.

[45]  Ming Zhang,et al.  A jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomes , 2006, BMC Bioinformatics.

[46]  A. Mocroft,et al.  Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. , 2005, The Journal of infectious diseases.

[47]  M. Graf,et al.  Characterization of a Virtually Full-Length Human Immunodeficiency Virus Type 1 Genome of a Prevalent Intersubtype (C/B′) Recombinant Strain in China , 2000, Journal of Virology.